Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients.A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine.//Estrategias antihipertensivas Perindopril arginina/Amlodipino versus Valsartan/Amlodipino: Eficacia y seguridad en pacientes hipertensos de leves a moderados.Estudio aleatorizado, doble ciego durante 6 meses y que se continúa con un seguimiento a largo plazo en abierto durante 8 meses con Perindopril arginina/Amlodipino
Phase 1
- Conditions
- Essential arterial hypertension//Hipertensión arterial esencialMedDRA version: 12.1Level: LLTClassification code 10020775Term: Hypertension arterial
- Registration Number
- EUCTR2010-020945-28-ES
- Lead Sponsor
- Itziar Fernandez Gonzalez
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 1600
Inclusion Criteria
- Paientes ambulatorios,
- Homabres ó mujeres
- igual ó mayor de 18 años,
- paciente hipertenso de leve a moderado.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Mujeres embaradas ó en periodo de lactancia,
- Hipertensión secundaria,
- Caulquier paciente que sufra una enfermedad aguda ó crónica
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method